Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy. Galafold ...
Abstract: This article discusses a design method of a high gain frequency reconfigurable Fabry-Perot cavity antenna, which is suitable for electromagnetic compatibility (EMC) application in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results